Fluticasone propionate/salmeterol combination in children with asthma: Key cardiac and overall safety results

Clinical Research and Regulatory Affairs

Volumn 27, Issue 3, 2010, Pages 87-95

  Li, Jennifer S ^a   Qaqundah, Paul Y ^b   Weinstein, Steven F ^c   Laforce, Craig F ^d   Ellsworth, Anna V ^e   Ortega, Hector G ^e   Ferro, Thomas J ^e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Pediatric Medical Care Group Inc   (United States)

^c Research Center   (United States)

^d North Carolina Clinical Research   (United States)

^e GLAXOSMITHKLINE   (United States)

Author keywords

ECG; Inhaled corticosteroid; Long acting beta agonist; Pediatric; QRS; QTc

Indexed keywords

FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; HYDROCORTISONE;

ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; ECG ABNORMALITY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY MONITORING; FALSE POSITIVE RESULT; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE CONDUCTION; HUMAN; HYDROCORTISONE URINE LEVEL; INFECTION; INFESTATION; INHALATION SPACER; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM DISEASE; METHODOLOGY; MULTICENTER STUDY; NEUROLOGIC DISEASE; PHARYNGITIS; PRESCHOOL CHILD; QRS COMPLEX; QT INTERVAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; RHINITIS; RHINOPHARYNGITIS; RR INTERVAL; SCHOOL CHILD; SCREENING; SIDE EFFECT; SINUS TACHYCARDIA; SINUSITIS; SORE THROAT; SUPRAVENTRICULAR PREMATURE BEAT; THORAX DISEASE; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

EID: 77955913431     PISSN: 10601333     EISSN: 15322521     Source Type: Journal    
DOI: 10.3109/10601333.2010.499912     Document Type: Article

References (22)

1. Akinbami L. Asthma prevalence, health care use and mortality: United States, 2003-2005. NCHS Health E-Stats; November 2006. Available online at: http://www.cdc.gov/nchs/products/ pubs/pubd/hestats/asthma03-05/asthma03-05.htm, accessed 20 August 2009.
2. Expert Panel Report III Full Report Update 2007. National Asthma Education and Prevention Program Expert Panel Report: guidelines for the diagnosis and management of asthma. Available online at: http://www.nhlbi.nih. gov/ guidelines/asthma/index.htm, accessed 20 August 2009.
3. Randell TL, Donaghue KC, Ambler GR, Cowell CT, Fitzgerald DA, van Asperen PP. Safety of the newer inhaled corticosteroids in childhood asthma. Paediatr Drugs 2003;5:481-504.
4. Sorkness CA, Lemanske RF, Jr, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Bloomberg GR, Covar RA, Guilbert TW, Heldt G, Larsen G, Mellon MH, Morgan WJ, Moss MH, Spahn JD, Taussig LM; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Long-term comparison of 3 controller regimens for mildmoderate persistent childhood asthma: The Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007;119:64-72.
5. Malone R, LaForce C, Nimmagadda S, Schoaf L, House K, Ellsworth A, Dorinsky P. The safety of twice daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistant asthma. Ann Allergy Asthma Immunol 2005;95:66-71.
6. Lenney W, Pedersen S, Boner AL, et al. Efficacy and safety of salmeterol in childhood asthma. Eur J Pediatr 1995;154:983-990.
7. Bronsky EA, Pearlman DS, Pobiner BF, Ebbutt A, Jenkins MM. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of two salmeterol powder delivery devices. Pediatr 1999;104:501-506.
8. Morganroth J, Gussak I. Cardiac safety of noncardiac drugs. Totowa: Humana Press; 2005.
9. Park MK, Guntheroth WG. Ventricular conduction disturbances. How to read pediatric ECGs. 4th ed. Philadelphia: Mosby Elsevier; 2006. p 83-95.
10. Behrman RE, Kliegman RM, Jensen HB. Nelson textbook of pediatrics. 17th ed. Philadelphia: Saunders; 2004.
11. Davignon A, Rautaharju P, Boisselle E, Soumis F, Megela M, Choquette A. Normal ECG standards for infants and children. Ped Cardiol 1979;1:123-131.
12. Rijnbeek PR, Witsenburg E. New normal limits for the paediatric electrocardiogram. Eur Heart J 2001;22:702-711.
13. Pauker SG, Kopelman RI. Clinical problem solving. How sure is sure enough? N Engl J Med 1992;326:688-691.
14. GlaxoSmithKline. Prescribing Information, ADVAIR® HFA. November 2008. Available online at: www.us-gsk.com/products/ assets/us-advair-hfa.pdf, accessed 4 August 2009.
15. Bracamonte T, Schauer U, Emeryk A, Godwood A, Balsara S. Efficacy and safety of salmeterol/fluticasone propionate combination delivered by the Diskus® or pressurized metered dose inhaler in children with asthma. Clin Drug Invest 2005;25:1-11.
16. Nair A, Menzies D, Barnes M, Burns P, McFarlane L, Lipworth B. Respirable dose delivery of fluticasone propionate from a small valved holding chamber, a compact breath actuated integrated vortex device and a metered dose inhaler. Br J Clin Pharmacol 2008;66:20-26.
17. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-244.
18. Polgar G, Promadhat V. Pulmonary function testing in children, techniques and standards. Philadelphia: W.B. Saunders Co.; 1971.
19. Bazett, HC. An analysis of the time relationship of electrocardiograms. Heart 1920;7:353-370.
20. Fridericia, LS. Die systolendauer im elektrocardiogramm bei normalen menschen und bei herzkranken. Acta Med Scand 1920;53:469-486.
21. Milic M, Bao X, Rizos D, Liu F, Ziegler MG. Literature review and pilot studies of the effect of QT correction formulas on reported 2-agonist-induced QTc prolongation. Clin Ther 2006;28:582-590.
22. Gemello R, Mana F, Saitta L. Rigel. An inductive learning system. Mach Learn 1991;6:7-35.